TOXPIA 200 Units is a high-dose formulation of a Clostridium botulinum neurotoxin type A product, designed for professional aesthetic and medical use in the temporary improvement of dynamic facial lines and muscle hyperactivity. It offers a 200-unit vial format, intended for providers seeking a high-capacity vial for multiple treatment areas or high-volume practice.

Why Choose TOXPIA?

• Reduced appearance of expression lines: Specifically targeted at dynamic wrinkles caused by repetitive muscle contraction—such as glabellar (frown) lines, forehead lines, and crow’s-feet. For example, one supplier lists “temporary improvement of facial lines and reduction of muscle hyperactivity, particularly in: Glabellar Lines – Vertical frown …” for TOXPIA 200 U.

• High-dose format (200 Units): More capacity per vial compared with many standard 100-unit vials on the market—this may increase cost efficiency in busy practices.

• Advanced manufacturing/purity claims: The manufacturer (HJ Corporations, South Korea) states that TOXPIA is produced using vacuum-drying (lyophilisation) methods to improve stability and remove impurities.

• Professional-usage only: As per the supplier materials, the product is intended exclusively for licensed healthcare/aesthetic professionals and not for general consumer self-administration.

Usage & Dosage Guidelines

 

Detail	Instruction
Reconstitution	Use 0.9% sodium chloride (saline) under sterile conditions
Injection Sites	Glabellar area, forehead, underarms, neck, jaw, etc.
Onset of Action	Results in 3–5 days (average)
Duration	3–4 months (individual variation applies)
Aftercare	Avoid rubbing or lying flat for 4–6 hours post-injection

Note: Only to be administered by licensed medical professionals.

Competitive Edge: Why Choose TOXPIA?

 

Feature	TOXPIA 200U	Botox	Rentox
Purity	99% (SEC-HPLC)	95–97%	~98%
Drying Method	Vacuum-Dried	Freeze-Dried	Freeze-Dried
Unit Options	100U / 200U	100U	50U / 100U
Price Efficiency	High	Moderate	High
Origin	South Korea	USA	South Korea

 

FAQs

Q: Is TOXPIA a botulinum toxin?
A: Yes, it is a Botulinum Toxin Type A injectable product similar in function to Botox.

Q: What sets TOXPIA apart from Botox?
A: TOXPIA offers comparable performance with enhanced purity, vacuum-dried stability, and affordability. It’s especially favored in high-volume clinics seeking consistent results.

Q: What’s the difference between TOXPIA and Rentox?
A: Both are Korean botulinum toxins. TOXPIA is vacuum-dried for extended shelf-life, while Rentox is freeze-dried. Clinical performance is similar, but TOXPIA may offer more stability post-reconstitution.

Q: Is Korean Botox safe?
A: Korean brands like TOXPIA undergo rigorous safety testing and offer high purity, making them globally competitive and increasingly preferred in clinical settings.

Q: Does botulinum toxin enter the bloodstream?
A: No, when injected properly, it acts locally at the neuromuscular junction without systemic absorption.

Final Thoughts

TOXPIA 200U is more than just a wrinkle treatment—it’s a clinical-grade injectable solution that delivers safety, precision, and satisfaction. Whether you’re managing aesthetic outcomes or therapeutic needs, TOXPIA provides the performance, purity, and pricing modern clinics demand.

click here for more